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ABSTRACT
Non-genetic  heterogeneity  is  key  to  cellular  decisions,  as  even  genetically  identical  cells
respond in very different ways to the same external stimulus, e.g., during cell differentiation or
therapeutic treatment of disease. Strong heterogeneity is typically already observed at the level
of signaling pathways that are the first sensors of external inputs and transmit information to the
nucleus where decisions  are made.  Since heterogeneity  arises from random fluctuations  of
cellular components, mathematical models are required to fully describe the phenomenon and
to  understand  the  dynamics  of  heterogeneous  cell  populations.  Here,  we  review  the
experimental and theoretical literature on cellular signaling heterogeneity, with special focus on
the TGFβ/SMAD signaling pathway.  β/SMAD signaling pathway.  SMAD signaling pathway.  
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INTRODUCTION
Heterogeneity  is  an  implicit  part  of  life  that  is  observed  on  nearly  all  biological  scales  [1].
Perhaps the most  widespread effect  of  heterogeneity  is  the creation of  a wide spectrum of
lifeforms during evolution [2]. Primarily, heterogeneity aids robustness to a biological system in
a fluctuating environment, such that, a broader niche in phenotypic traits is collectively achieved
by  a  population  of  a  species,  which  may  then  add  to  better  chances  of  their  survival  [3].
However,  the presence of heterogeneity is observed at even finer levels - individuals within one
species  exhibit  unique  properties,  and  further,  genetically  identical  cells  within  the  same
(multicellular) organism utilizes heterogeneity to achieve distinct cell fate decisions  [1]. At the
level of single cells heterogeneity in expression of individual gene or protein (also called cell-to-
cell variability) may lead to cell-specific responses to external cues and distinct physiological
trajectories [1, 3].  
In this chapter, we provide an overview over cellular heterogeneity in the context of intracellular
signaling. We will specifically discuss how a signaling in a heterogeneous cell population can be
modelled  in  silico and  will  point  out  assumptions  underlying  these  models.  The  chapter  is
divided  in  three  parts:  In  the  first  Section,  we  describe  biological  systems where  signaling
heterogeneity plays a role in cellular decision making. Fβ/SMAD signaling pathway.  urthermore, we review evidence that
signaling heterogeneity is mostly deterministic in nature and discuss the molecular sources of
signaling heterogeneity.  In the second part,  we describe mathematical  modeling frameworks
that can be used to model heterogeneous cell populations and fluctuations in cellular signaling
pathways.  We mainly focus on deterministic modeling approaches using ordinary differential
equations, in which heterogeneity is introduced by parameter sampling and discuss approaches
for the quantitative fitting of single-cell models to experimental data. In the third part, we focus
on the TGFβ/SMAD signaling pathway.  /SMAD signaling pathway.  SMAD signaling  pathway that  plays a key role in  tissue homoeostasis  and cell
migration, but also in diseases such as cancer. We review the literature on single-cell analysis
of this pathway, and demonstrate that key features of heterogeneous TGFβ/SMAD signaling pathway.  β/SMAD signaling pathway.  SMAD signaling
can be understood by mechanistic modeling. We then discuss our recent modeling work, in
which  we  quantitatively  described  cellular  subpopulations  of  TGFβ/SMAD signaling pathway.  β/SMAD signaling pathway.  SMAD  signaling  and
heterogenous signaling at the single-cell level. As an outlook for future research, we summarize
how fluctuations in signaling pathways affect noisy downstream gene expression and decision
making.
1. Relevance and features of cellular signaling heterogeneity
1.1. Heterogeneity in cellular responses to external cues
Fβ/SMAD signaling pathway.  rom early microscopic observations in cell culture, it became clear that not all cells respond
identically to the same external stimulus. Intriguingly, it seems that not only genetic differences
between cells contribute to heterogeneity, but that non-genetic origins arising from stochasticity
in cellular  networks also play an important role. In recent years, evidence has accumulated
demonstrating that genetically identical  cells show differences in differentiation programs  [4],
drug resistance [5, 6], and viral pathogenesis [7]. In the following paragraphs, we provide a brief
summary of biological systems where heterogeneity plays a functional role in cellular behavior.
Stress responses in unicellular organisms: Heterogeneity  is an important  part  of  cellular
decision making, as evidenced by stochastic cellular differentiation events, where parts of a cell
population randomly enter a new fate. Well-known examples include bacterial stress responses
(e.g.,  [8]).  Fβ/SMAD signaling pathway.  or  instance,  during  bacterial  competence,  external  stress  induces  a  regulatory
program in  Bacillus subtilis that  allows cells  to take up DNA from the environment,  thereby
priming them for adaptation to stress conditions. In line with a stochastic event, it was shown
that  the  decision  to  become  competent  is  dictated  by  random  fluctuations  in  the  master
transcriptional regulator  ComK  [8]. In some cases, stochastic fluctuations in stress networks
occur constitutively, i.e., even in the absence of external stress. This phenomenon, known as
bet  hedging,  ensures  that  subsets  of  cell  populations  are  prepared  to  rapidly  respond  to
stressors,  thereby  ensuring  survival  of  the  population  in  case  of  external  changes.  In
Saccharomyces cerevisiae,  isogenic  clonal  populations display  a range of  growth rates and
slow  growth  predicts  resistance  to  heat  killing.  At  the  molecular  level,  Tsl1,  a  trehalose-
synthesis regulator, is a key component of the observed resistance, and cell-to-cell variability in
Tsl1 expression correlates with growth rate and predicts cellular survival in response to stress
[9].
Cellular differentiation: Likewise, in eukaryotes, cell fate decisions during tissue development
appear to occur stochastically in genetically  identical  cell  populations,  and this is thought  to
allow for a disversificvation of tissues. At the molecular  level,  evidence is accumulating that
random fluctuations in the levels of signaling pathways and master transcription factors govern
cell  fates  (Fβ/SMAD signaling pathway.  ig.  1A).  Fβ/SMAD signaling pathway.  or  instance,  in  Drosophila  melanogaster cell-to-cell  variability  in  the
expression of the transcription factor spineless creates the retinal mosaic for colour vision and is
thus important for the spatio-temporal organization of the eye [10]. Moreover, subpopulations of
clonally derived hematopoietic progenitor cells with low or high expression of a stem cell marker
(Sca-1) were observed to be in dramatically  different transcriptional  states and gave rise to
different blood cell lineages in multipotent murine hematopoietic cell line [4]. In developing mice,
cell-to-cell variability in the expression of certain genes (e.g., Fβ/SMAD signaling pathway.  gf4) was found to determine the
inner  cell  mass (ICM) lineage  segregation  of  the blastocyst  [11].  Fβ/SMAD signaling pathway.  urther  evidence for  non-
genetic heterogeneity and its impact on animal development comes from genetic mutations with
incomplete  penetrance.  These  mutations  cause  physiological  defects  only  in  a  subset  of
genetically identical animals. Fβ/SMAD signaling pathway.  or instance, during C. elegans development, the expression level
of elt-2, a self-activating transcription factor is critical for intestinal cell-fate specification. Strong
embryo-to-embryo heterogeneity in elt-2 expression and thus failure of intestinal development in
a subset of embryos is observed if the upstream regulator skn-1 is inactivated by a mutation.
Thus, the skn-1 mutant shows incomplete penetrance, likely because the lowered input signal
shifts heterogeneous elt-2 expression to a range, where its fluctuations have profound effects
on intestinal development [12] .   
Tumor progression and drug resistance: Cancer cell therapy aims for a complete eradication
of tumor cells.  However, in reality, complete killing is rarely achieved, as signaling pathways
involved in the execution of cell death fail to be activated in all cells and certain subpopulations
are therefore resistant to the therapeutic treatment (Fβ/SMAD signaling pathway.  ig. 1B). Thus, cytotoxic drugs often result
in fractional  killing,  especially  when the drug concentration inside a tumor is limiting.  In cell
culture,  fractional killing has been reported in response to a variety of  treatments,  including
chemotherapy and apoptosis-inducing receptor ligands such as TRAIL  [5,  6,  13–16].  At  the
molecular level, fractional killing involves cell-to-cell variation in cellular regulatory molecules,
e.g.,  in  the  tumor  suppressor  p53  in  response  to  chemotherapy  [6][.   Thus,  non-genetic
variability  may confer  resistance  to  therapeutic  intervention  and could  play  a  role  in  tumor
evolution [17]. 
These examples demonstrate that cellular heterogeneity can have a strong impact of cell fate
decisions  in  biological  systems.  It  is  therefore  crucial  to  quantitatively  measure  cellular
heterogeneity using experimental methods such as live-cell imaging, flow cytometry or single-
cell  RNA  sequencing  (reviewed  in  [18–23]).  Fβ/SMAD signaling pathway.  urthermore,  predictive  modeling  approaches
describing  the  variability  of  molecular  networks  at  the  single-cell  level  will  be  essential  to
rationally  manipulate  cellular  differentiation  processes  and  to  design  effective  combinatorial
therapeutic intervention strategies.
1.2. Heterogeneity in the activity of cellular signaling pathways
The above examples of stochastic decision making mainly focused on cellular fluctuations in
nuclear transcription factors. Signaling pathways controlling these master transcription factors
similarly show strong non-genetic cell-to-cell variation that is linked to cell fate. This was initially
shown  for  mitogen-activated  protein  kinase  (MAPK)  signaling  and  later  extended  to  other
signaling systems.   
In  a  pioneering  study,  the  group  of  James Fβ/SMAD signaling pathway.  errell  analyzed  Xenopus  oocyte  maturation  in
response to the maturation-inducing hormone progesterone  [24]. This maturation response is
mediated by the MAPK signaling pathway and due to the large size oocytes the authors could
perform single-cell Western Blot experiments to determine cell-to-cell variation in the activity of
this pathway. They showed that MAPK signaling was activated in an all-or-none manner within
individual cells, i.e., every oocyte either had low or high (but not intermediate) MAPK activity
level, and MAPK activity therefore showed a bimodal distribution (Fβ/SMAD signaling pathway.  ig. 1C, right). This switch-like
(ON or OFβ/SMAD signaling pathway.  Fβ/SMAD signaling pathway.  ) MAPK activation with strong heterogeneity between cells caused maturation in
only a fraction of cells, and ON/SMAD signaling pathway.  OFβ/SMAD signaling pathway.  Fβ/SMAD signaling pathway.  -switching was shown to arise from a positive feedback at
the  level  of  the  signaling  pathway  [24].  Likewise,  switch-like  and  heterogeneous  MAPK
activation was reported to be involved in other cell fate decisions such as T cell activation [25],
PC12 cell differentiation [26] and in the UV stress response mediated by the closely related JNK
MAPK signaling pathway [27]. Thus, MAPK signaling frequently mediates switch-like and highly
heterogeneous cell fate decisions. However, the pathway can also be gradually activated, with a
unimodal but heterogeneous distribution of activity states in the population (Fβ/SMAD signaling pathway.  ig. 1C, left), e.g., in
EGFβ/SMAD signaling pathway.  -stimulated  fibroblasts.  There,  the  pathway  transmits  quantitative  information  to  the
nucleus, and switch-like cell fate decisions are established at the level of downstream gene-
regulatory networks  [28, 29] In conclusion, heterogeneity in MAPK signaling is a widespread
phenomenon, but the qualitative features (uni- vs. bimodal distribution) of the heterogeneous
population can vary, implying plasticity in network behavior. 
Other signaling systems seem to be less flexible in their signaling output.  Fβ/SMAD signaling pathway.  or instance, the
apoptosis  signaling system, involved in sensing cytotoxic stress and death receptor signals,
seems to invariably induce heterogeneous all-or-none responses at the level of the executing
caspase  enzymes  (e.g.,  [30]).  This  may  ensure  that  programmed  cell  death  is  executed
completely and irreversibly, but only a fraction of cells in a tissue, thereby preventing complete
loss of all cells in a tissue. Yet other signaling pathways such as Akt [31, 32], and TGFβ/SMAD signaling pathway.  β/SMAD signaling pathway.  SMAD
[33, 34] signaling show a heterogeneous, but gradual (unimodal) response in the majority of
cellular systems studied. Thus, these signaling pathways transmit quantitative information about
extracellular  stimulus  concentration  from  the  cell  membrane  to  the  nucleus,  where  gene-
regulatory networks mediate cell fate decisions. 
One  important  question  in  signal  transduction  is  how  accurate  information  transmission  is
possible despite strong heterogeneity in the activity of gradual signaling pathways. Based on a
combination of quantitative experiments, mathematical modeling and concepts from information
theory  it  became  clear  that  quantitative  information  is  frequently  encoded  in  the  temporal
dynamics (i.e.,  the shape)  of  the signal  [35–38].  Fβ/SMAD signaling pathway.  or instance,  the NFβ/SMAD signaling pathway.  kB signaling  pathway
shows oscillatory dynamics and the nature of activated target genes in the nucleus depends on
the  frequency  and  amplitude  of  the  signaling  pathway  oscillation  [39].  Another  concept  for
reliable signal transmision despite signaling heterogeneity is relative signal transmission, where
the (noisy) absolute signaling activity is less important for cellular behavior when compared to
the  (more  robust)  stimulus-induced  fold-change  over  basal  [29,  40–43].  Combined  live-cell
imaging and modeling studies support this concept for Erk, Wnt and TGFβ/SMAD signaling pathway.  β signaling pathways,
and it has also been described how downstream gene-regulatory networks in the nucleus could
respond to fold-changes rather than absolute signaling levels [40–42]. 
Taken together, both gradual and bimodal signaling pathways show strong cell-to-cell variability
in their activity. Single-cell experiments characterize quantitative information transmission and
switch-like decision making in a heterogeneous cell population and therefore provide a basis for
quantitative modeling.  
1.3 Signaling fluctuations are often non-genetic and temporally stable
To model  signaling  heterogeneity,  assumptions  need to be made about  the properties  and
origins of the fluctuations. Evidence from the literature suggests that signaling heterogeneity is
non-genetic and that the cell-specific features of signaling can be assumed to be temporally
stable during a typical cellular stimulation experiment.    
Cell cultures are often derived from tumor cells and are thus potentially genetically unstable.
This raises the question of whether heterogeneity in signaling pathways is really non-genetic in
nature.  Strong  evidence  for  a  non-genetic  contribution  to  heterogeneity  in  signaling  events
comes from re-stimulation experiments with ligands and drugs triggering cell death (Fβ/SMAD signaling pathway.  ig. 1B). In
several of these studies, an initial treatment killed the majority of the cell population and the
cells were kept in culture for several days before they were subjected to another treatment with
the same stimulus. Even though the initial survivors were resistant to the first treatment a large
part of  them became sensitive to the second treatment (Fβ/SMAD signaling pathway.  ig. 1B).  Thus, resistance was not
inherited to all  offspring of resistant cells, i.e., genetically determined, but was gradually lost
during several days of culture, arguing for an epigenetic mechanism of heterogeneity [5, 13, 44,
45].  
A  second  line  of  evidence  for  a  non-genetic  signaling  heterogeneity  came from sister  cell
experiments, in which cells and their division events were tracked before stimulation to record
cellular progeny (Fβ/SMAD signaling pathway.  ig. 1D). A common observation in these lineage tracing experiments is that
freshly  divided  sister  cells  show very similar  signaling  responses,  and that  the similarity  of
sisters got  lost  over time after  the common division event.  Fβ/SMAD signaling pathway.  or instance,  for  TRAIL-induced
apoptosis, it was shown that freshly divided sister cells have a high correlation in the death time,
i.e.  the time it  takes for the TRAIL stimulus to induce cell  death  [46]. Thus, the experiment
suggests that sister cells are initially in a very similar (signaling) state, but interestingly they
loose the signaling similarity with a characteristic half-life of 11h (after the common division
event). Similar observations were made for other regulatory networks, including the cell cycle,
the  spindle  assembly  checkpoint,  MAPK  as  well  TGFβ/SMAD signaling pathway.  β  signaling  [33,  47–50].  Sister  cell
experiments  have  several  important  implications  for  cellular  signaling  heterogeneity,  and
mathematical modeling thereof:
1. Fβ/SMAD signaling pathway.  irst, they further support non-genetic sources of heterogeneity, since the loss of sister cells
similarity on a time scale of hours is much faster than any genetic drift due to DNA mutations.
2. Second, the initially high sister cell similarity suggests that heterogeneity does not arise from
stochastic  dynamics  in  signaling  reactions:  If  signaling  molecules  are  present  in  very  low
amounts, signaling reactions (e.g., phosphorylation) could be probabilistic events that give rise
to strong heterogeneity and high dissimilarity in the signaling events of freshly divided sisters (or
even  high  dissimilarity  if  the  same  cell  would  be  stimulated  repeatedly).  Certain  signaling
pathways indeed show such stochastic dynamics (see Section 2.3 and [51]), but the sister cell
experiments suggest that this is typically not the case, which agrees with the fact that signaling
proteins are often expressed at high molecule numbers [52].
3.  Third,  the  time  scale  of  sister  cell  similarity  (multiple  hours)  suggests  that  signaling
heterogeneity can be assumed to be stable at the time scale of a typical stimulation experiment
(minutes  to  hours).  The  conclusion  of  temporal  stability  is  also  supported  by  a  recent
restimulation  analysis  with  insulin-like  growth  factor,  in  which  the  rank  of  single-cells  with
respect to Akt signaling activity was stable over several hours [32] . 
These conclusions greatly simplify the mathematical modeling of cellular signaling pathways, as
stochastic  modeling  of  signaling  dynamics  can  be  neglected  in  most  cases.  Instead,  a
deterministic  ordinary  differential  equation  approach  can  be  used,  in  which  certain  kinetic
parameters are assumed to be different between cells, but stable over time. 
1.4. Signaling heterogeneity arises from fluctuations in signaling protein levels 
To introduce heterogeneity into a mathematical model, we need to know the molecular sources
of temporally stable signaling pathway fluctuations. Obvious sources for signaling fluctuations
are  cell-to-cell  differences  in  cell  cycle  stage  [19] or  cell  density  [53].  In  growing  adherent
mammalian cells,  cell  divisions combined with cell  motility can create variations in local cell
densities, cell–cell contacts, relative location, and the amount of free space per cell. Combined,
these  parameters  constitute  the population  context  of  an  individual  cell  [54,  55].  However,
single-cell signaling studies exist where these sources have been excluded experimentally, but
the heterogeneity in the signaling output persists [33, 48, 51]. 
In  recent  years,  it  has  become  apparent  that  random  fluctuations  in  the  total  cellular
concentrations  of  signaling  proteins  may  underlie  temporally  stable  cell-to-cell  variability  in
signaling pathway activity (Fβ/SMAD signaling pathway.  ig. 1E). In some cases, signaling heterogeneity could be traced
back  to  fluctuations  in  the  expression  of  specific  signaling  molecules,  e.g.,  in  MAPK  [25],
PI3K/SMAD signaling pathway.  Akt [56] and JAK/SMAD signaling pathway.  STAT [57] signaling. Fβ/SMAD signaling pathway.  or instance, a pioneering work on T cell activation
showed that MAPK activation depends on cell-to-cell variability in the expression of the CD8 co-
receptor  and the antagonizing  phosphatase  SHP-1.  Interestingly,  even though each protein
contributes to variability, co-regulation of CD8 and SHP-1 expression levels at the single-cell
level  limits  diversity  and promotes robustness of  signaling  [25].  In  other  systems,  signaling
heterogeneity cannot be explained by fluctuations in a single protein, but the control seems
distributed over many protein levels. Fβ/SMAD signaling pathway.  or example, in their work on apoptosis signaling, Spencer
et al showed that no single protein level could accurately predict cell death timing in response to
TRAIL treatment, unless a specific pathway regulator (BID) was overexpressed and its cellular
level then became a good predictor of cell death timing [46].  
Even  in  genetically  identical  cell  populations,  (signaling)  proteins  show  strong  cell-to-cell
variability in their levels, since epigenetic control and gene expression are stochastic events at
the single-cell level (see also Section 2.3): Each gene is present only at two copies (alleles) per
cell  and  gene  regulation  at  such  low  molecule  numbers  is  probabilistic  [58–61].  As  a
consequence, each (signaling) protein level  follows a log-normal distribution, that is, the fold-
change of a protein is normally distributed around its population mean [46, 58, 62]. Although the
mean and standard deviation of the distribution are protein-specific, a typical human protein
shows a three-fold difference in expression across the cells of a population (where the fold-
change is measured between the 10th and 90th precentile of the distribution) [47, 58]. This strong
variation in each and every signaling protein leads to strong fluctuations in signaling.  Time-
resolved measurements further suggest  that fluctuations in signaling  protein expression and
pathway  activity  are  coupled:  when  protein  expression  fluctuations  in  mammalian  cells  are
followed over time, the time scale of stochastic changes in protein expression is similar to the
time scale of signaling pathway desynchronization between sister cells (multiple hours to days)
[46, 58]. This is consistent with a model, in which sister cells initially share the same proteome
content  and  signaling  activity,  and  then  over  time  and  simultaneously  loose  both  types  of
similarity due to stochastic gene expression fluctuations [46, 47, 58]. 
Taken together,  these observations indicate that  mammalian signaling proteins show strong
fluctuations in their levels. In the following, we will discuss deterministic modeling approaches of
cellular signaling pathways in which cell-to-cell variability in signaling protein concentrations is
taken into account.
METHODS
2. Mathematical modeling of cellular heterogeneity
Signaling pathways often respond in very similar manner to stimulation when the same cell is
stimulated repeatedly, or when sister cells are in a similar state and harbor a similar proteome
content. These observations suggest that cells respond deterministically to stimulation and that
deterministic mathematical modeling approaches can be used to simulate cellular heterogeneity
in silico. Such deterministic models are often based on ordinary differential equations (ODEs)
which represent reaction networks within the cell,  typically using mass action-based reaction
kinetics (reviewed in [63]). ODE models assume that the biochemical molecules in the cell are
present  in  sufficiently  large amounts (and well-stirred),  so that  stochastic fluctuations at  the
single-molecule level can be neglected and the biochemical species can be described using
continuous variables,  representing average molar signaling protein concentrations within the
cell. If an ODE system is simulated twice with the same set of kinetic reaction parameters and
initial conditions (i.e., protein concentrations) it will yield exactly the same solution, representing
the deterministic nature of the apporach. This determinism is in contrast to stochastic simulation
algorithms (reviewed in [64]) which explicitly describe single-molecule fluctuations and therefore
give rise to distinct simulation results for each realization.       
In  this  Section,  we  discuss  how  intracellular  signal  transduction  in  a  heterogeneous  cell
population can be modelled  in silico. We mainly focus on deterministic ODE-based modeling,
and  point  out  how  these  models  can  provide  insights  into  several  aspects  of  cellular
heterogeneity, including noisy decision making and the robustness of signaling networks. We
then  discuss  how  these  models  can  be  calibrated  based  on  single-cell  data  to  obtain  a
quantitative match between experiment and theory.  Fβ/SMAD signaling pathway.  inally,  we briefly summarize stochastic
modeling approaches that are relevant for the modeling for some signaling networks operating
at  low molecule  numbers and particularly  for  gene-regulatory networks involved  in  cell  fate
decisions downstream of signaling pathways.
2.1 Applications and limitations of population-average models 
Experiments aimed at understanding intracellular processes were tradionally performed in bulk,
combining  material  from  thousands  to  millions  of  cells.  Fβ/SMAD signaling pathway.  or  instance,  signaling  pathway
dynamics  were  studied  using  Western  Blot  experiments,  in  which  phosphorylated  signaling
intermediates are detected using phospho-specific antibodies [24, 65]. Due to averaging over a
large  number  of  cells,  these  experiments  do  not  provide  information  about  single-cell
heterogeneity,  but  only represent  the behavior  of  one hypothetical  average cell.  In systems
biology, early quantitative models were built  based on the available population-average data
and therefore describe one representative cell (Fβ/SMAD signaling pathway.  ig. 2A). 
Even though not  meant  to  represent  cellular  heterogeneity,  population-average models  can
provide important insights into several signaling phenomena at the single-cell  level including
cellular decision making and robustness of networks against fluctuations in their components.
Fβ/SMAD signaling pathway.  or instance, Fβ/SMAD signaling pathway.  errell  et al (1998) showed that the decision of Xenopus oocyte maturation in
response to progesterone involves  an all-or-none biological  response at  the level  of  MAPK
signaling (see Section 1.2; [24]). To better understand this single-cell phenomenon, the authors
constructed a population-average model of the signaling network, and concluded that switch-like
(bistable) behavior in the MAPK cascade arises from a positive feedback loop that amplifies the
signal once MAPK signaling exceeds a certain threshold. Likewise, other population-average
modeling  studies  provided  insights  into  mechanisms  of  switch-like  decision  making  and
therefore have implications for bimodal behavior at the single-cell level [26, 66–71]. Population-
average  models  further  provided  insights  into  biological  robustness  against  fluctuations  in
signaling  protein  concentrations  [25,  72–75]:  Fβ/SMAD signaling pathway.  or  example,  using  single-cell  experiments,
Kamenz et al (2015) observed that the timing of mitotic events is highly robust and is buffered
against variations in the concentrations of mitotic regulatory proteins [75]. A population-average
model could explain the observed robustness and predicted conditions where mitotic timing is
compromised.  Thereby,  the  population-average  model  identified  critical  transitions  in  the
network and experimental validation showed that these transitions led to network failure in a
subset of cells due to cell-to-cell variability in the molecular components. In general, for gaining
insights into robustness, a so-called sensitivity analysis can be performed, in which the initial
conditions  and  kinetic  parameters  are  systematically  perturbed  (usually  one  at  a  time)  to
understand their role in the behavior of the network. Given that cellular signaling fluctuations
often arise from cell-to-cell  variability in signaling protein expression (Section 1.4), sensitivity
analyses focusing on the impact of signaling protein concentrations at the population level can
provide valuable insights into biological variability and robustness in single cells [25]. However,
though  potentially  useful,  population-average  models  do  not  directly  represent  signaling
distributions across single cells (as those shown in Fβ/SMAD signaling pathway.  ig. 1C), and therefore do not allow for a
quantitative comparison of the model simulations to a single-cell  experiment. Fβ/SMAD signaling pathway.  urthermore, a
population-average  model  constructed  based  on  population-average  data  may  lead  to
misleading conclusions for cell fate decision networks with ON/SMAD signaling pathway.  OFβ/SMAD signaling pathway.  Fβ/SMAD signaling pathway.  -behavior [24, 62]: In binary
decision  making,  single  cells  show  show  all-or-none  (digital)  signaling,  but  do  so
heterogeneously for a given stimulus concentration. Hence, the activity distribution is bimodal
(Fβ/SMAD signaling pathway.  ig.  1C),  and  the  mean  response  of  the  population  gradually  increases  with  increasing
stimulation. Therefore, at the population-average level, digital responses may appear gradual
(analogue) when averaged.  
Taken together, population-average models fail to quantitatively describe single-cell distributions
and can only be as insightful  as the experimental  data they are based on. Models that are
designed  solely  based  on  population-average  data  implicitely  assume  that  the  population-
average data is a good approximation for the true underlying single-cell behavior, and therefore
may lead to wrong conclusions. To overcome, these limitations, models of cellular heterogeneity
were developed to quantitatively describe the cell-to-cell variability in signal transduction. 
2.2 Deterministic models of signaling heterogeneity – implementation and scope
How does a deterministic model of cellular signaling heterogeneity look like? In most cases,
heterogeneity is simulated using an ensemble of single-cell models (Fβ/SMAD signaling pathway.  ig. 2A). Here, individual
cells are described by repeating the simulation using the same deterministic ODE model, each
simulation run corresponding to one cell, and cell-to-cell variability is introduced by perturbing
the model in each realization. 
Based  on  the  arguments  presented  in  Section  1.4,  the  perturbation  leading  to  cell-to-cell
variability  is  mainly  introduced  by  assuming  cell-specific  signaling  protein  concentrations.
Additionally, kinetic parameters can be assumed to be cell-specific if the corresponding reaction
rates are in turn controlled by (fluctuating) proteins (this may, for example, be true for enzymatic
reactions). Given that protein expression levels are log-normally distributed (see Section 1.4),
single-cells  are  modeled  by  repeated simulations  in  which  all  protein  concentrations  in  the
model  are  sampled  from  independent  log-normal  distributions  (Fβ/SMAD signaling pathway.  ig.  2A).  In  this  approach,
sometimes  termed  Monte-Carlo  sampling  or  non-linear  mixed  effect  modeling,  the  protein
fluctuations are typically restricted to a biologically reasonable range. Specifically, the coefficient
of variation of the lognormal distribution (CV = std /SMAD signaling pathway.   mean) is chosen between 0.1 and 0.4 [46,
58, 62]. Since proteins from the same pathway may co-regulated at the single-cell level  [58],
sometimes correlated fluctuations in signaling protein fluctuations are assumed  [33]. Notably,
sampling  only  the  initial  total  protein  concentrations  and  leaving  the  model  otherwise
unperturbed, assumes that non-genetic sources of signaling heterogeneity are temporally stable
during  pathway  stimulation.  Hence,  the  modeling  framework  captures  the  key  features  of
cellular signaling heterogeneity, including deterministic behavior, temporal stability and protein
concentrations as a noise source (Section 1).  
Compared  to  a  population-average  model,  such  single-cell  ensemble  modeling  approaches
reproduce the complete heterogeneous cell population and allow for a quantitative comparison
of the model to experimental single-cell data. Specifically, while the population-average model
by definition only represents the mean, ensemble models capture higher momentum statistics of
the heterogeneous model  species such as the standard deviation,  their  correlations or  time
course  features  such  as  the  autocorrelation  function  (e.g.,  [46]).  Deterministic  ensemble
modeling approaches have been used in a several studies on signaling, often in combination
with experimental analyses at the single-cell level [14, 15, 76–85, 16, 86, 87, 35, 41, 46, 49, 62,
70,  72].  These  models  provided  experimentally  testable  predictions  and  led  to  a  better
understanding  of  heterogeneous  signal  transduction.  In  particular,  the  following  phenomena
were analyzed (Fβ/SMAD signaling pathway.  ig. 2C):
1)  Sources  of  signaling  fluctuations: Ensemle  models  were  used  characterize  how
fluctuations  in  individual  signaling  protein  expression  levels  affect  the  signaling  outcome.
Thereby, the most critical signaling protein expression fluctuations could be identified as main
sources of cell-to-cell variability in signal transduction [16, 33, 46, 49, 57, 87–89]. This led to a
better  understanding  of  molecular  mechansisms  causing  heterogeneous  cellular  decision
making.
2) Design principles of biological robustness:  Robust and reliable signal transduction must
occur despite strong noise. By adding or removing certain reactions in the models, insights were
gained  into  design  principles  that  mitigate  signaling  variability  [41,  62,  72,  80],  thereby
promoting robustness, e.g., during embryonic development [72]. Several robustness-promoting
network motifs could be identified including negative feedback  [72, 80], fold-change detection
[41] and  correlated  expression  fluctuations  in  positive  and  negative  regulators  of  signaling
pathways [80, 86].     
3)  Characterization  and  manupulation  of  heterogeneous  decision  making: Fβ/SMAD signaling pathway.  or  cellular
differentiation and during stress responses, cell-to-cell variability may be beneficial, as not all
cells of a heterogeneous population enter a new fate and die in response to stress, respectively
(see Section 1.1).  Modeling of signaling pathways involved in cellular differentiation and cell
death allowed for a quantitative analyses of decision making at the level of signaling, and thus
for the emergence of bimodal signaling distributions.  The models yielded predictions for the
reprogramming  of  cell  fates  for  novel  experimental  conditions  [83,  84] and  allowed  for  the
optimization of therapeutic treatment responses in cell culture [14–16, 82]   
4) Insights into alternative biological mechanisms and network topologies: Since certain
network motifs affect the characteristics of biological fluctuations (see above), attempts were
made to infer (reverse engineer) the wiring of signaling networks based on single-cell data. The
idea is that signaling fluctuations contain a fingerprint for the underlying molecular interactions,
and that the model topology that best describes the signaling fluctuations is the most probable
one. Several studies used a defined model topology and compared a set of relatively minor
modifications in the model against single-cell data [85, 90].  In a less biased top-down approach,
Sachs  et  al  inferred  the  topology  of  signaling  networks  from  single-cell  data  without  prior
knowledge using a Bayesian framework [91]. 
5.  Integration  of  single-cell  and  population-average  data:  Ensemble  models  of  cell
populations allow for simulations at both the single-cell and population-average levels, and can
thus be used to integrate both types of data [33, 57, 85]. Thereby, the models on the one hand
exploit highly informative single-cell data which often can be done only at low throughput and for
few molecular species (especially for time-resolved live-cell imaging). On the other hand, they
take into account  population-average information that  can more easily  collected for  multiple
experimental  conditions  and  molecular  species.  Accordingly,  the  integration  of  population-
average and single-cell data led to a better discrimination of competing model hypotheses when
fitting an emsemble model to experimental data [85]. 
2.3 Stochastic modeling of signaling and gene expression heterogeneity
Signal transduction cascades typically control cellular decisions by activating gene expression
responses in the nucleus. Expression of target genes (e.g., cell cycle regulators or cell adhesion
molecules) then controls the morphological features of a cell such as cell division and migration.
In addition, target genes often act as negative feedback regulators that downregulate the signal
once gene expression has been activated [52]. Thus, signaling and gene expression responses
are intimately connected, and both may need to be taken into account in realistic models of
cellular decision making. In this context, it should be pointed out that determinstic models may
no longer be suitable for modeling of cellular  heterogeneity if  gene expression is taken into
account, e.g., for modeling  transcriptional feedback or nuclear propagation of the signal.  
The reason is that gene regulation is an intrinsically stochastic process with strong temporal
fluctuations (reviewed in [59], although deterministic sources of heterogeneity sources (i.e., the
cellular state) also seem to play a role  [54, 60]. Stochastic behavior arises from the fact that
transcriptional regulators are typically expressed at very low levels, and that a cell contains only
two copies of each gene. As a result, random (Brownian) fluctuations at the level of individual
reactions are not averaged out and significantly impact on the activity of a gene, especially at
the level of mRNA production. Therefore, stochastic approaches are typically used for modeling
heterogeneity  of  gene  expression  [59,  64].  In  early  work,  Arkin  and  colleagues  used  the
Gillespie algorithm to simulate biochemical reactions leading to gene expression, and predicted
stochastic cell-to-cell variation in protein numbers for biologically realistic parameter ranges [92,
93].  The  prediction  of  stochastic  mRNA  and  protein  expression  was  later  confirmed
experimentally in bacteria and mammalian cells (reviewed in  [59]). In higher organisms, noise
seems to be larger in magnitude compared to bacteria, since chromatin states seem to give rise
to  switching  of  genes  between  ON  and  OFβ/SMAD signaling pathway.  Fβ/SMAD signaling pathway.   states.  In  time  courses  of  single-cell  gene
expression, this is observable as transcriptional bursts, i.e., episodes of high gene expression
that are separated by phases with low activity  [60, 61, 94, 95].  The simplest stochastic model
which  realistically  describes  transcriptional  bursts  is  the  so-called  random telegraph  model,
where a  gene promoter is assumed to reversibly switch between a transcriptional active and an
inactive state (reviewed in  [59]).  Notably,  depending on the gene under  consideration more
promoter states may need to be taken into account to describe the data  [94, 96]. To jointly
model  signal  transduction  and  gene  expression,  these  stochastic  promoter  models  were
coupled to deterministic models of signaling, and this yielded insights into the dynamics of target
gene  expression  [97,  98] and  into  the  long-term  regulation  of  signaling  heterogeneity  by
stochastic signaling protein expression fluctuations [82]. 
In certain cases, intrinsic stochastic dynamics may arise within the signaling network, especialy
if the pathway operates at low molecule numbers [51, 98, 99]. The level of initial signal sensing
may be especially  prone to stochastic dynamics, since cell  surface receptors are often only
expressed at a few hundreds or thousand molecules per cell  [52, 100]. Then, processes like
receptor endocytosis which simultaneously remove hundreds of molecules at once from the cell
surface, may give rise to digital  behavior  and consequently strong stochastic fluctuations of
signaling  activity  [101].  Accordingly,  stochastic  models  of  signaling  networks  have  been
proposed to describe heterogeneous decision making  [51, 97, 99, 100], and several of these
studies focussed on fluctuations at the receptor level [97, 99, 100].   
2.4 Quantitative modeling of cellular heterogeneity
In  many cases,  ensemble modeling  approaches are semi-quantitative in  the sense that  the
kinetic  reaction parameters and the protein fluctuations (i.e.,  the standard deviation  of  their
distribution) are tuned manually.  While  such semi-quantitative modeling is valuable in many
cases, the long-term goal is a quantitative match between model and experiment. This can be
achieved by directly fitting the single-cell models to single-cell data by minimizing the difference
between the simulated and measured single-cell distributions. 
Quantitative singe-cell model fitting of signaling and gene expression has now been applied in a
number of publications and is an lively area of research [57, 60, 85, 86, 88–90, 94, 102–111]. In
several of these studies, the fitted models involve deterministic sources of heterogeneity [85, 86,
107], stochastic fluctuations  [94], or a combination of both  [60, 88, 105]. In the deterministic
case, only signaling protein concentrations may be cell-specific parameters  [85] or all  model
parameters  may  show  cell-to-cell  variability  [89]. Fβ/SMAD signaling pathway.  or  a  comprehensive  overview  over  the
assumptions and the computational methods, we refer to the recent review by Hasenauer and
Loos [112]. 
The methods for model calibration can be classified based on the type of experimental data they
use,  single-cell  snapshot  or  time course data (Fβ/SMAD signaling pathway.  ig.  2D and  [112]).  Fβ/SMAD signaling pathway.  or  snapshot  data,  only
distributions at single time points are considered and therefore potential correlations between
observations at  consecutive time points  are neglected.  Despite this  limitation,  the approach
benefits from the fact that snapshot data can typically be generated on a higher throughput, i.e.,
for  more cells  and molecular  species,  when compared to time-resolved measurements.  Fβ/SMAD signaling pathway.  or
instance,  high-throughput  snapshot  data  can  be  generated  using  flow  cytometry,  mass
cytometry  or  single-cell  RNA  sequencing,  and  the  larger  wealth  of  information  should  be
beneficial  for  the  training  of  reliable  mathematical  models.  Accordingly,  several  approaches
were were proposed for the model calibration based on snapshot data [88–90, 102, 104, 111].
In  deterministic  models,  different  assumptions  were made about  the  type of  fluctuations  in
parameter  values,  ranging  from  the  unimodal  log-normal  distribution  of  to  multimodal
distributions, or even no specific assumption was made about the nature of fluctuations (non-
parametric distribution; reviewed in [112]). Fβ/SMAD signaling pathway.  or instance, Hasenauer et al. employed multi-modal
mixtures  of  normal  parameter  distributions  to  infer  subpopulations  (with  distinct  mean
parameters) by fitting a model NGFβ/SMAD signaling pathway.   signaling to snapshot data [102]. 
A limitation of the snapshot approach is that essential information about temporal behavior in
single cells gained from live-cell imaging (e.g., an oscillatory pattern) may be lost. Therefore,
snapshot  information  may be less  well  suited  for  the  identification  of  molecular  sources of
heterogeneity when compared to time-resolved data (discussed in  [110]). As a consequence,
several studies suggested to directly fit a mechanistic model to single-cell time course data [85,
86,  103,  105–110].  In  naive  approach,  each  individual  cell  could  be  fitting  separately  by
minimizing the residuals between model and data, and then the single-cell  fitting results are
combined to yield cell population distributions of interest, e.g., for signaling protein expression
levels.  In  this  so-called  standard  two-stage  approach,  each  cell  is  thus  analyzed  as  a
independent  sub-problem  (stage  1),  and  then  the  cell  population  is  assembled  (stage  2).
However,  stage  1  suffers  from the problem that  the  model  parameters  in  systems biology
models  can  almost  never  be  correctly  estimated  (identified),  especially  based  on  live-cell
imaging data which typically only covers one molecular species for each cell. Thus, the fitting
uncertainties are high and the heterogeneity between cells is overestimated  [106, 107] which
limits the predictive power of the two-stage approach unless very small models are considered.
To circumvent this problem, information about the cell population distribution needs to be taken
into account during fitting of single-cells  [85, 106, 107, 110]. Specifically, the fitted likelihood
function  combines  information  from  all  cells,  and  these  additional  constraints  improve  the
identifiability of single-cell parameters which leads to smaller uncertainties in model predictions.
Fβ/SMAD signaling pathway.  or  instance,  as  a  constraint  in  deterministic  models,  it  can  be  ensured  that  protein
concentration fluctuations follow a log-normal distribution [85, 106]. Moreover, the model can be
simultaneously fitted to single-cell and population-average data, and it has been shown that the
combination of both types leads to a better discrimination of model variants compared to the use
of either alone [85]. 
It should be noted that the current quantitative models of cellular signaling and gene expression
heterogeneity  are  typically  limited  to  a  few  species  and  reactions.  Therefore,  qualitative
ensemble modeling approaches (Section 2.2) are still  very valuable for large-scale networks
and  typically  led  to  more  profound  “biological”  insights  when  compared  to  quantitative
approaches. Fβ/SMAD signaling pathway.  urther improvements are needed in the computational methods for quantitative
model fitting to reduce computational cost and to integrate various types of data including cross-
sectional  snapshots,  high-resolution  live-cell  imaging  and population-average data.  This  will
improve identifiability of model parameters, the certainty of model predictions and will be helpful
to discriminate competing model variants also in larger networks.    
3. Heterogeneity in TGFβ-SMAD signaling pathwayβ signaling - modeling and impact on cellular
behaviour
In the final part of the chapter, we discuss the characteristics and modeling of TGFβ/SMAD signaling pathway.  β/SMAD signaling pathway.  SMAD
signaling at the single-cell level. We initially start with an overview over the pathway and its role
in controlling cell fates. Then, we summarize its dynamic features at the single-cell level and
outline how population-average as well  as single-cell  modeling approaches provided insights
into  the  pathway  dynamics.  Fβ/SMAD signaling pathway.  inally,  we  review  recent  work,  in  which  the  link  between
fluctuations in SMAD proteins and target gene expression was explored. 
3.1 TGFβ-SMAD signaling pathwayβ signaling in health and disease
TGFβ/SMAD signaling pathway.  β belongs to a family of soluble extracellular ligands that activate intracellular signaling by
binding to cell surface receptors. As depicted in Fβ/SMAD signaling pathway.  ig. 3A, signaling is initiated by a cascade of
events that involves TGFβ/SMAD signaling pathway.  β binding to the TGFβ/SMAD signaling pathway.  βR2 receptor, and this receptor-ligand complex in
turn  binds  to  the  TGFβ/SMAD signaling pathway.  βR1  receptors  (also  known  as  ALK5)  to  build  an  activated  receptor
complex  [113] .  The  active  TGFβ/SMAD signaling pathway.  β  receptor  functions  as  as  a  intracellular  kinase  that
phosphorylates cytoplasmic SMAD2/SMAD signaling pathway.  3 proteins which upon phosphorylation form heterotrimers
with SMAD4 (e.g.,  (SMAD2)2(SMAD4)).  SMAD heterotrimers translocate to the nucleus and
there act as transcription factors, i.e., they bind to and activate gene promoters to regulate the
target  gene  expression  [114].  The  signaling  pathway  activity  is  terminated  by  nuclear
dephosphorlyation of SMAD proteins, dissociation of the complexes and finally the nuclear exit
of SMAD proteins. 
TGFβ/SMAD signaling pathway.  β induces several cellular responses including cell cycle arrest, apoptosis and cell migration
[115].  TGFβ/SMAD signaling pathway.  β-induced cell  migration typically  involves the so-called  epithelial-to-mesenchymal
transition (EMT), a phenotypic remodeling of cells in which the cytoskeletal reorganization and
loss of cell-cell junctions allows epithelial cells to evade from their original location by acquiring
a motile,  migratory, mesenchymal phenotype  [116]. Given these widespread roles in cellular
remodeling, it is not surprising that TGFβ/SMAD signaling pathway.  β and closely related ligands (e.g., GDFβ/SMAD signaling pathway.  11 or BMPs)
play a critical  role in embryogenesis  and tissue homeostasis,  but  also in  diseases such as
cancer or fibrosis [117]. Fβ/SMAD signaling pathway.  or instance, in higher vertebrate development, gastrulation and neural
crest formation depend on EMT induced by  TGFβ/SMAD signaling pathway.  β superfamily members [116] . Likewise, TGFβ/SMAD signaling pathway.  β
induced apoptosis and cell cycle arrest maintain tissue homeostasis and prevent overgrowth in
developing and adult tissues, e.g., in the liver [118].  If the cytostatic effect of TGFβ/SMAD signaling pathway.  β or is its
ability to induce apoptosis is lost this leads to tumor progression. However, TGFβ/SMAD signaling pathway.  β signaling not
only acts as a tumor suppressor, but plays a dual role in cancer progression, as in late-stage
tumors aberrant  TGFβ/SMAD signaling pathway.  β induced EMT signaling  promotes the formation of  metastasis  [119].
Thus, during cancer development, a specificity switch occurs, in which TGFβ/SMAD signaling pathway.  β signaling no longer
promotes cytostatic responses, but mostly induces cell migration. 
At  the  molecular  level,  this  specificity  switch  involves  a  change  in  the  set  of  target  genes
regulated  by  TGFβ/SMAD signaling pathway.  β/SMAD signaling pathway.  SMAD  signaling:  In  late-stage  tumors,  TGFβ/SMAD signaling pathway.  β  no  longer  downregulates
growth-promoting oncogenes like Myc and fails to upregulate cell  cycle inhibitors (e.g.,  p15,
p21). Instead, TGFβ/SMAD signaling pathway.  β induces gene expression changes that are crucial for mediating early steps
of  reprogramming  from  epithelial  to  mesenchymal  identity  including  the  downregulation  of
classical  epithelial  and upregulation of  mesenchymal markers  [119].  Based on experimental
evidence, several hypotheses have been  been proposed to explain how the same signaling
pathway can induce qualitatively distinct gene expression responses depending on the cellular
context: (1) context-specific expression of transcription co-factors involved in SMAD-dependent
gene expression  [120], (2) alterations in the concentrations of SMAD2 and SMAD3  each of
which controls specific sets of target genes [121] or (3) encoding of specific gene expression
programs by the temporal dynamics of the SMAD pathway [122, 123]. Specifically, it has been
suggested that a transient SMAD signal may be sufficient for EMT and cell  migration, while
sustained signaling additionally triggers cell cycle arrest  [122]. Thus, quantitative insights into
the pathway dynamics by time-resolved live-cell imaging  [18] and mathematical modeling are
important to better understand cellular responses to TGFβ/SMAD signaling pathway.  β stimulation.
3.2 Lessons learned from single-cell experiments of TGFβ-SMAD signaling pathwayβ signaling
At the single-cell level, individual cells respond very differently to TGFβ/SMAD signaling pathway.  β treatment. Due to this
heterogeneity, time-resolved analyses of SMAD signaling at the single-cell level are valuable
tools to understand the link between signaling dynamics, gene expression and cellular outcome.
In fact,  single-cell  studies further supported that the amplitude and/SMAD signaling pathway.  or duration of the SMAD
signal  partially determines whether a cell will react at all to stimulation and/SMAD signaling pathway.  or whether it will
respond with migration or cell cycle arrest [33, 36]. 
Established  experimental  readouts  of  TGFβ/SMAD signaling pathway.  β/SMAD signaling pathway.  SMAD signaling  at  the  single-cell  level  include
measurements of receptor levels and their internalization [124], nuclear translocation of SMAD
proteins [33, 34, 41, 125, 126], SMAD trimerization [127] and SMAD-induced gene expression
[34, 72]. At the signaling level, SMAD nuclear translocation assays are most widely used. They
rely  on the mild  overexpression  of  SMAD2 or  SMAD4 fluorescent  fusion  proteins,  and  the
nuclear translocation of the fluorophore is then used as a proxy for pathway activation. [33, 34,
36, 41, 126, 128] By automated microscopy, images are taken on a temporal resolution of a few
minutes. Subsequently image analysis is performed to track cells, and to segment them into
nuclear  and  cytoplasmic  compartments.  The  amount  of  SMAD-associated  fluorophore  in
nucleus or the  nucleus-to-cytoplasmic fluorescence ratio is then used as a measure of signaling
pathway activity. Depending on the study, this technique allowed for signaling analysis in 250-
1500 single cells per condition over a time frame of 45 min to 24h.  
These  large-scale  single-cell  datasets  indicated  that  heterogeneous  SMAD signaling  at  the
single-cell level exhibits a few key features that are recurrently observed across experimental
groups and cellular systems:    
1) SMAD signaling is gradual at the single-cell level (Fig. 3C): In Section 1, it was discussed
that certain signaling pathways like the MAPK and apoptosis cascades, show bimodal behavior,
i.e., complete or no activation in individual cells. Available single-cell studies on TGFβ/SMAD signaling pathway.  β signaling
suggest that this pathway rather acts like a gradual continuum, i.e.,  snapshot histograms of
SMAD2 nuclear translocation show a unimodal distribution with strong cell-to-cell variability (Fβ/SMAD signaling pathway.  ig.
3C). With increasing TGFβ/SMAD signaling pathway.  β doses, this mean value of this continuous distribution gradually shifts
to higher signaling levels  [33, 34, 41, 125, 128]
2) Single cells show qualitative differences in signal shape (Fig. 3B): Single-cell analyses
show  strong  differences  in  the  absolute  level  of  SMAD2  or  SMAD4  nuclear  translocation
between cells at a given time point  [33, 34, 36, 41, 128]. In time-resolved analyses, individual
cells  may also  be distinct  in  the shape of  the signal,  e.g.,  in  the kinetics or  the degree of
adaptation to a lower pleateau after the initial peak amplitude. Such heterogeneity in the shape
of the signal was observed either at the level of SMAD2 or SMAD4 nuclear translocation  [33,
34, 125], or at the level of target gene expression [34]. In contrast, in other cellular systems the
shape  of  SMAD2  nuclear  translocation  was  fairly  similar  between  cells  [129].  Clustering
techniques using dynamic time warping as a  similarity measure between cells were used to sort
the  trajectories  of  individual  cells  into  classes  with  qualitatively  different  dynamics  [33,  34].
Using this clustering approach, we found that even for a given TGFβ/SMAD signaling pathway.  β dose some cells do not
respond  to  the  stimulus  (non-responders),  others  show a  transient  response,  whereas  the
remainder show sustained pathway activation (Fβ/SMAD signaling pathway.  ig. 3B). At very low TGFβ/SMAD signaling pathway.  β stimulation,  most
cells belong to the non-responding cluster, whereas at intermediate and high TGFβ/SMAD signaling pathway.  β doses, the
transient and sustained clusters predominate, respectively. Population-average measurements
are a mixture of  these qualitatively  distinct  responses and therefore only  partially  cover the
complexity of the pathway at the single-cell level. Interestingly, the signalling clusters are better
predictors  for  TGFβ/SMAD signaling pathway.  β-induced  cell  migration  and  division  when  compared  to  the  applied
extracellular  ligand dose  [33].  This  further suggests that  the cellular  decisions are linked to
SMAD signaling dynamics at the single-cell level.  
3) Single cells show burst-like shuttling of SMAD proteins (Fig. 3B): Upon stimulation, the
population-average response of the SMAD signaling pathway typically shows an initial  peak
amplitude ~60 mins after stimulation. Afterwards, the population-average signal slowly declines
over a time scale of several hours, but may remain constantly elevated, e.g., upon strong TGFβ/SMAD signaling pathway.  β
stimulation, but this depends on the cellular context. Fβ/SMAD signaling pathway.  or such sustained behavior, the single-cell
response  is  distinct  from  the  population  average  and  shows  repeated  bursts  of  nuclear
translocation (Fβ/SMAD signaling pathway.  ig. 3B). Specifically, the nuclear SMAD2 or SMAD4 levels decline strongly after
the initial peak, before again reaching once or multiple times levels comparable to the level of
the initial peak  [33, 34]. This did not appear to a technical artefact of imaging, as a generic
nuclear marker (H2B) did not show bursting behavior  [130]. Fβ/SMAD signaling pathway.  urthermore, SMAD4 bursts were
reported in developing Xenopus embryos in which TGFβ/SMAD signaling pathway.  β family ligands play an important role,
and the behavior could be reproduced in isolated animal cap explants [128] Interestingly, these
pulsatile  SMAD translocation dynamics are irregular  in their timing intervals and amplitudes,
suggesting  that  they  may,  in  part,  arise  from  stochastic  dynamics  of  the  SMAD  signaling
pathway.
In  the  following,  we  will  discuss  how mathematical  models  can  provide  insights  into  these
dynamical features at the single-cell  level.  We will  first review population-average models of
TGFβ/SMAD signaling pathway.  β/SMAD signaling pathway.  SMAD signaling and will then turn to modeling approaches at the single-cell level.
3.3 Population-average models of TGFβ-SMAD signaling pathwayβ/SMAD signalingSMAD signaling
Early kinetic models of TGFβ/SMAD signaling pathway.  β/SMAD signaling pathway.  SMAD signaling mainly focused on the description of Western Blot
measurements of  SMAD2/SMAD signaling pathway.  3 phosphorylation  and complex formation  [131–139]. Since these
experimental  methods provide average quantifications  of  thousands  to millions  of  cells,  the
resulting  models  describe the behavior  of  a  representative  average cell  and fail  to  capture
heterogeneity  in  the population.  Population-average models of  SMAD signaling are typically
based on deterministic ordinary differential equations (ODEs), and the individual reaction steps
are  formulated  based  on  mass-action  kinetics.  Models  proposed  in  literature  have  been
reviewed elsewhere [140, 141] and differ in the level of detail they consider and in the reaction
mechanisms they focus on. Still, most of the models share a set of key mechanisms including
receptor-ligand  binding,  receptor  shuttling  to  the  endosome,  receptor-mediated  SMAD
phosphorylation SMAD (de)phosphorylation, trimerization and nuclear translocation, as well as
transcriptional negative feedback via target genes that, for instance, inhibit receptor signaling
(Fβ/SMAD signaling pathway.  ig.  3A).  The kinetic  parameters are typically  not  known and were estimated by fitting the
models to experimental data [33, 135, 142], or the parameter space was explored by random
sampling or sensitivity analysis [132, 134, 143, 144]. 
Interestingly,  population-average models alongside with  quantitative experiments reproduced
and  provided  insights  into  several  features  of  heterogeneous  TGFβ/SMAD signaling pathway.  β/SMAD signaling pathway.  SMAD signaling  at  the
single-cell level including the gradual behavior of the pathway, transient vs. sustained signaling
and pulsatile pathway dynamics. Thus, they provide hints to mechanisms of heterogeneity and
serve as a basis for deterministic modeling of variability at the single-cell level.
1)  Gradual  dose-response  behavior:  Population-average  modeling  studies  and  dose-
response  measurements  revealed  gradually  increasing  SMAD  signaling  in  response  to
increasing doses of TGFβ/SMAD signaling pathway.  β. Specifically, intracellular SMAD signaling exhibits a shallow dose-
response curve with a Hill coefficient (nH) of close to or less than 1 [33, 72, 136, 145]. Modeling
studies further revealed that switch-like dose-response behavior (nH=4.5) late after stimulation
(24 h) is not an inherent feature of the SMAD signaling pathway, but arises from degradation of
extracellular  TGFβ/SMAD signaling pathway.  β in the cell  culture  dish  [136,  146].  Hence,  the SMAD signaling  pathway
models respond gradually to perturbations (in both TGFβ/SMAD signaling pathway.  β concentration and intracellular protein
concentrations)  and  are  therefore  consistent  with  a  unimodal  SMAD  nuclear  translocation
distribution at the single-cell level. 
2) Features controlling signal  amplitude and duration:  Sensitivity analysis  of  population-
average  models revealed the relative importance of individual reaction steps in controlling the
signal amplitude and duration [133–136]. It seems that the signal duration (i.e., the shape of the
signal)  is  mainly  set  by  the  kinetics  of  receptor-ligand  binding  and  receptor  shuttling.
Accordingly, SMAD nuclear translocation cycle typically shows similar dynamics as the receptor
level and mainly acts as a remote sensor that directly reflects receptor changes, though with a
slight time delay of ~10 minutes  [133, 147]. Molecular mechanisms that control the signaling
dynamics at the receptor (and thus the SMAD) level include: (i) Receptor downregulation from
the cell surface by internalization of receptor-ligand complexes into endosomal compartments
[137,  148];  (ii)  Cell-mediated  degradation  of  extracellular  TGFβ/SMAD signaling pathway.  β,  again  by  internalization  of
receptor-ligand complexes and subsequent intracellular degradation of the ligand.  [131, 136].
This mechanism of signal termination becomes an important factor in controlling the length of
the  signal  if  the  number  of  extracelluar  TGFβ/SMAD signaling pathway.  β  molecules  per  cell  is  limiting  (low  TGFβ/SMAD signaling pathway.  β
concentration and/SMAD signaling pathway.  or small extracellular medium volume) (iii) Negative feedback of SMAD target
genes to the receptor level, e.g., by SMAD-induced expression of inhibitory SMAD7 and BAMBI
proteins.  These  proteins  bind  to  TGFβ/SMAD signaling pathway.  β  receptor  complexes,  thereby  inhibiting  their  kinase
activity and targeting them for degradation [33, 134, 139]. Taken together, the signal duration is
controlled by multiple mechanisms at the receptor level. Using sensitivity analysis of population-
average models,  a similar  multi-level regulation by many reaction steps in the pathway was
shown for the absolute scale (i.e., the amplitude) of the SMAD signal [133, 135]. At the single-
cell level, such mechanisms jointly control heterogeneous signaling dynamics and this can be
investigated by parameter sampling in a deterministic model (see below).  
3)  Pulsatile  SMAD  shuttling:  Population-average  modeling  and  quantitative  experimental
analyses  suggested  that  SMAD signaling  induced  by  TGFβ/SMAD signaling pathway.  β or  BMP could  show (damped)
oscillatory behavior, in which a single stimulus induces two or more repeated pulses of SMAD
nuclear translocation  [134, 148]. Using global parameter sampling, Wegner et al proved that
oscillations  require  the  presence  of  transcriptional  negative  feedback  -  if  this  feedback  is
switched off, no physiologically plausible parameter configuration can produce oscillations [134].
Accordingly, knockdown of transcriptional feedback regulators SMAD6 and SMAD7 abolished
BMP-induced SMAD oscillations  [148].  It  is  possible  that  such oscillatory negative feedback
contributes to repeated bursting of SMAD2 or SMAD4 nuclear translocation observed in single
cells, though additional stochastic mechanisms need to be taken into account to describe the
irregularity of bursts [33, 128].
3.3 Towards quantitative modeling of SMAD signaling heterogeneity
On the basis of the established population-average models, we recently derived a deterministic
modeling framework to quantitatively describe cell-to-cell variability in the TGFβ/SMAD signaling pathway.  β/SMAD signaling pathway.  SMAD signaling
pathway  [33].  Our  study  was  based  on  imaging  data  in  which  the  nuclear  translocation  of
SMAD2/SMAD signaling pathway.  4-GFβ/SMAD signaling pathway.  P fusion proteins was monitored in thousands of living MCFβ/SMAD signaling pathway.  10A cells over 24 h. 
As  a  basis  for  modeling,  we  initially  analyzed  characteristic  features  of  SMAD  signaling
heterogeneity. We performed sister cell experiments and found that sister cells are more similar
than random pairs of cells but desynchronize after several hours. This indicated that signaling
fluctuations  are  non-genetic,  but  temporally  stable.  We  then  analyzed  potential  sources  of
heterogeneity in SMAD signaling, and considered that SMAD signaling may be influenced by
cell cycle stage and/SMAD signaling pathway.  or cell density [127, 149]. Using live-cell imaging, we followed cell division
events and quantified the cell density before and during TGFβ/SMAD signaling pathway.  β stimulation, and found that these
two factors had negligible impact on heterogeneous signaling in our culture conditions. Taken
together, this indicated that SMAD signaling heterogeneity can be modeled using a deterministic
approach based on ODEs (Section 2), with the assumption of stochastic (but temporally stable)
fluctuations in signaling protein expression levels.
We started with a detailed kinetic pathway model that describes known mechanisms of SMAD
signaling and comprises a total of 23 molecular species and 45 kinetic reaction parameters. Like
most  other  models  of  TGFβ/SMAD signaling pathway.  β signaling,  our  model  contained the main features described in
Section  3.3, including an endosomal receptor shuttling module, a SMAD translocation module
and a transcriptional feedback module (Fβ/SMAD signaling pathway.  ig. 3A). With this model, we sought to describe a large
experimental dataset, in which several levels of signaling (TGFβ/SMAD signaling pathway.  β receptor expression, nuclear
translocation of SMAD2 and SMAD4, as well as SMAD7 mRNA expression) were measured for
multiple experimental conditions at the single-cell and population-average levels. In total, this
dataset  comprised  >1,000,000  data  points,  mainly  from  densely  sampled  live-cell  imaging
experiments at multiple experimental conditions.  Owing to the high complexity of model and
data, we did not aim for a quantitative fitting of the model to the single-cell data, but instead
devised a three-tiered, modeling strategy to derive a quantitative description of heterogeneous
signaling (Fβ/SMAD signaling pathway.  ig. 3D). Initially, we describe the population-average dynamics. Then, we refine the
description of  the pathway to the level cellular  sub-populations showing qualitatively  distinct
signaling  dynamics.  Fβ/SMAD signaling pathway.  inally,  we develop  an ensemble  of  single-cell  models  to  describe  the
complete heterogeneous cell population. Specifically, the three modeling steps were as follows:
1) Population-average modeling:  To derive a quantitative description of the SMAD signaling
dynamics, we initially fitted the model to population-average data (Fβ/SMAD signaling pathway.  ig. 3D, left). Fβ/SMAD signaling pathway.  or fitting, we
used the population-median nuclear translocation time courses of fluorescently labeled SMAD2
and SMAD4 for varying TGFβ/SMAD signaling pathway.  β doses and for restimulation experiments, in which cells were
repeatedly  challenged  with  the  ligand.  Fβ/SMAD signaling pathway.  urthermore,  the  fitting  took  into  account  pathway
measurements that were only possible at the population-average level (TGFβ/SMAD signaling pathway.  β receptor protein
expression, SMAD7 mRNA expression). After calibration, we validated the predictive power of
our  model  for  previously  untested  molecular  species  (time  course  of  extracellular  TGFβ/SMAD signaling pathway.  β
degradation) and experimental conditions (restimulation experiments, inhibition of transcriptional
feedback loops by small molecule inhibitor DRB). 
2)  Description of cellular subpopulations:  Having a predictive population-average model at
hand,  we  sought  to  quantitatively  describe  variability  in  signaling,  while  limiting  the
computational cost. Therefore, we refrained from fitting our model to the complete single-cell
population  (Section  2.4),  but  only  fitted  six  subpopulations  which  show qualitatively  distinct
dynamics of signaling (e.g., transient vs. sustained; see Fβ/SMAD signaling pathway.  ig. 3D, middle). These subpopulations
were identified by k-means clustering of single-cell SMAD2 nuclear translocation time courses
according to their similarity in shape and amplitude.  We separately fitted the subpopulation-
median time course of each cluster and only allowed variation in the expression of signaling
proteins (e.g., TGFβ/SMAD signaling pathway.  β receptors, SMADs) within the range of typical cell-to-cell variation (+/SMAD signaling pathway.  - 2-
fold). In contrast, the kinetic parameters were fixed to their population-average value, i.e., their
variability  was  neglected.  With  these  assumptions,  we  could  quantitatively  describe  all
subpopulations, and had therefore developed our model from a population-average description
to a description of six representative cells with characteristic dynamical features. 
3) Ensemble modeling of complete cell population: To directly compare our simulations to
single-cell experiments, we converted the subpopulation models to an ensemble of artificial cells
representing the heterogeneity of the entire cell population (Fβ/SMAD signaling pathway.  ig. 3D, right). Artificial single cells
belonging to each subpopulation were generated by repeated simulation with signaling protein
concentrations varying around the best-fit  values of the corresponding subpopulation model.
The full cell  population was assembled  in silico by combining artificial  cells according to the
experimentally observed proportion of corresponding subpopulations. The degree of variation
was assumed to be the same for all sampled signaling proteins. The common protein coefficient
of variation (std/SMAD signaling pathway.  mean) was chosen by matching the simulated and and experimentally observed
snapshot distributions at particular time points using summary statistics.
Taken together, we obtained an  in silico cell  population with realistic properties close to the
experimental  data.  Importantly,  we  could  show that  our  three-tiered  modeling  approach,  in
which  we considered  the subpopulation  structure (step 2),  yielded  a better  agreement  with
single-cell  snapshot  distributions  (step  3)  when  compared  to  direct  sampling  of  protein
concentrations in the population-average model. The model reproduced key features of single-
cell TGFβ/SMAD signaling pathway.  β signaling including gradual (unimodal) behavior and strong heterogeneity in the time
course shape (Section 3.2). By calculating euclidean distances, we quantitatively compared the
simulated single-cell trajectories to the six experimentally observed time course clusters. Since
the  model  took  into  account  subpopulation  information,  we  obtained  a  very  similar  dose-
dependent decomposition into non-responding, transient and sustained signaling classes as for
the experimental  data. Thus, the model correctly takes into account temporal correlations in
signaling pathway activity, and can be used to predict drifts in the shape and proportion of the
original subpopulations for any experimental condition. In fact, we confirmed such predictions to
a knockout of the negative feedback regulator SMAD7. As predicted by the model, we found
that  the  effect  of  SMAD7  on  the  signaling  dynamics  was  restricted  to  certain  cellular
subpopulations and was observed for specific doses of TGFβ/SMAD signaling pathway.  β only. Hence, the model allowed
us  to  quantitatively  understand  the  cell-specific  impact  of  experimental  perturbations  and
allowed mechanistic insights into cellular heterogeneity.   
One limitation of the current model is that the best-fit parameter values in population-average
and  subpopulation  fitting  are  not  unique  (non-identifiability  problem).  Nevertheless,  robust
predictions could be made, since very similar simulation results were obtained when comparing
multiple  fits  obtained  during  a  multi-start  optimization  (repeated  model  fitting  from different
starting parameters). The subpopulation fitting (step 2) currently corresponds to a the standard
two-stage  approach  discussed  in  Section  2.3, since  the  protein  concentrations  in  each
subpopulation  were  estimated  separately  without  additional  constraints  about  the  protein
distribution in the cell population. After assembly of the complete cell population (step 3), we
confirmed that  signaling  protein levels  in  the model  show a realistic  log-normal  distribution.
However, such a distribution is not automatically granted in the current approach. Therefore, it
would be beneficial to either improve the identifiability of parameters by model reduction, or to
take into account additional constraints during subpopulation fitting.   
Taken together, our study suggest that heterogeneity of TGFβ/SMAD signaling pathway.  β/SMAD signaling pathway.  SMAD signaling at the single-cell
level can be quantitatively described using a deterministic modeling approach. Key features of
the  pathway  at  the  single-cell  level  were  reproduced,  including  gradual  behavior  and  cell-
specific characteristics in signaling shape. Since the model is deterministic in nature, it currently
does  not  describe  the  apparently  stochastic,  burst-like  shuttling  of  SMAD proteins  into  the
nucleus  (Section  3.2).  To  describe  this  phenomenon,  stochastic  effects,  most  likely  in
endosomal receptor shuttling need to be taken into account, and quantitative fitting approaches
could be used to match burst features in  the stochastic model to the experimental data. This
may be an interesting future direction, as other signaling pathways such as the MAPK cascade
show repeated pulses of activation which have profound impact on cell fate [43, 150].      
3.4 Fβ-SMAD signaling pathwayuture directions - Link between signaling and gene expression heterogeneity
Another  aspect  that  deserves further  attention  in  the  future is  how fluctuations  in  signaling
proteins translate into fluctuations in downstream target gene expression. SMAD transcription
factors mediate cellular responses by binding to target gene promoters, thereby inducing large-
scale gene expression programs involved in cell  migration, EMT and cell  cycle arrest  [115].
Given this link between SMAD binding and gene expression, it seems that cell-specific gene
expression  and  morphological  changes  may be predictable  based  on the amplitude  and/SMAD signaling pathway.  or
dynamics of SMAD signaling. In fact, by clustering single-cell SMAD time courses, we found
that cell migration and cell division kinetics can - in part - be explained based on the dynamics
of SMAD nuclear translocation [33].
Based on these observations, it  is natural to extend current mathematical models to SMAD-
induced gene expression and -in the long run– to TGFβ/SMAD signaling pathway.  β-induced cell  fate decisions.  At  the
population-average  level,  SMAD  signaling  dynamics  seem  indeed  to  be  related  to  gene
expression,  as  models  simultaneously  describing  time  courses  at  both  levels  are  well-
established:  most  of  these  studies  modeled  the  dynamics  of  certain  negative  feedback
regulators or pathway targets using SMAD-dependent transcription and linear degradation of
the  target  gene.  By  simultaneously  fitting  such  synthesis  and  decay  models  using  SMAD
kinetics as an input, target gene mRNA dynamics can be well-explained in multiple cases [33,
72, 134, 143, 146, 151, 152]. A recent combined modeling and experimental study extended
this idea to a larger set of target genes based quantitative and time-resolved measurements
SMAD trimeric  complexes  [142].  Using  a  model  fitting  framework,  the  authors  inferred  the
specificity of target gene induction by distinct SMAD complexes and successfully predicted gene
expression outcomes for novel experimental  conditions.
Despite  such  good  accordance  of  SMAD signaling  and  gene  expression  responses  in  cell
populations,  it  remains challenging to directly link both levels in single cells.  Experimentally,
such analyses require SMAD signaling dynamics and gene expression to be simultaneously
measured in the same cell by live-cell imaging of fluorescent SMAD reporters and subsequent
smFβ/SMAD signaling pathway.  ISH of mRNA expression in fixed cells [34, 41]. Those two studies conducted so far, agree
that on a single cell level, neither SMAD2 nor SMAD4 absolute levels in the nucleus accurately
predict  the cell-specific expression of target mRNAs. However,  Fβ/SMAD signaling pathway.  rick et al.  reported that the
TGFβ/SMAD signaling pathway.  β-induced  fold-change  of  the  nuclear SMAD  levels  relative  to  basal  predicts  stimulus-
induced  target  gene  expression  responses.  Fβ/SMAD signaling pathway.  or  the  genes  Snail  and  CTGFβ/SMAD signaling pathway.  ,  they  found
Spearman rank correlation coefficients of ~0.5 between between those fold-changes and the
mRNA abundance as measured by smFβ/SMAD signaling pathway.  ISH. These findings could not be confirmed by Tidin et
(2019),  who  analyzed  the  expession  of  CTGFβ/SMAD signaling pathway.   with  high  temporal  resolution  using  live
luminescence imaging. They found no correlation between the fold-changes in nuclear SMAD
and CTGFβ/SMAD signaling pathway.   expression. Thus, even though the proposed fold-change detection in SMAD target
gene  expression  may  be  an  elegant  way  to  reliably  respond  to  stimulation  despite  high
variability in absolute nuclear SMAD levels, it remains to be confirmed whether this is general
phenomenon applicable to other genes and cellular systems.
Therefore,  the  mechanistic  link  between SMAD signaling  fluctuations,  gene expression and
heterogeneous cellular responses remains to be established. In any case, a deterministic 1:1
correspondence  of  signaling  and  gene  expression  appears  unlikely,  since  gene  expression
modeling requires stochastic modeling of promoter switching, as Molina et al showed for SMAD
target genes (see also Section 2.3)  [153]. Even though each individual gene might respond
stochastically and with little correlation to the SMAD signal, it still remains possible that SMAD
signaling fluctuations directly affect cellular outcomes through their cumulative effect on many
target  genes  controlling  a  common  biological  process.  Genome-wide  single-cell  RNA
sequencing approaches will shed light on such coordinated gene expression programs at the
level of individual cells. 
Recent work has presented methods for the targeted manipulation of SMAD signaling dynamics
at the single-cell level [36, 126] and similar tools were developed for other signaling pathways
[43,  83,  154].  The  combination  of  such  highly  controlable  tools  with  gene  expression
measurements will provide direct insights into the impact of SMAD signaling dynamics on gene
expression outcomes, and will advance our understanding of heterogeneous decision making
by the TGFβ/SMAD signaling pathway.  β pathway.     
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Fβ-SMAD signaling pathwayIGURE LEGENDS
Fβ-SMAD signaling pathwayigure 1: Fβ-SMAD signaling pathwayunctional and physiological consequences of non-genetic heterogeneity. 
(A)  Heterogeneous  signaling  causes  fractional  cell  differentiation.  Only  cells  exhibiting  high
signaling activity (dark grey) in response to a differentiation stimulus undergo differentiation,
e.g., during MAPK-induced oocyte maturation or PC12 differentiation (see text). 
(B) Signaling variability in response to therapeutic treatment. Apoptotic signaling pathways (e.g.,
caspases) are activated heterogeneously when cells are treated with a cytotoxic drug which
results in fractional killing and (transient) resistance in the non-responding cells. A population
regrown from the therapy-resistant cells may again exhibit the same  fractional killing, indicating
that signaling heterogeneity is a non-genetic phenomenon. 
(C)  Heterogeneous  signaling  may  exhibit  gradual  or  bimodal  behavior.  Gradual  signaling
pathways exhibit a unimodal activity distribution across single cells which is shifted to higher
mean  levels  upon  increasing  stimulation.  Signaling  histograms  at  different  doses  typically
overlap, which may give rise to inaccurate cellular information transfer. Signaling systems with
bimodal  behavior  exhibit  two clearly  separable  (“ON”  and  “OFβ/SMAD signaling pathway.  Fβ/SMAD signaling pathway.  ”)  activity  levels.  Increasing
stimulation does not affect the mean signaling activity of the ON and OFβ/SMAD signaling pathway.  Fβ/SMAD signaling pathway.   subpopulation, but
shifts the fraction of cells in each class.
(D) Sister cells experiments indicate deterministic behavior of signaling. Fβ/SMAD signaling pathway.  or a signaling pathway
with stochastic  dynamics,  even recently  divided sister  cells  would  show distinct  (stochastic)
signaling responses. In signaling, recently divided sister cells are typically more correlated in
their  signal  response  than  random  cells,  likely  because  sisters  show  common  protein
expression patterns or cell cycle stages. Over a timescale of hours to days, sister cell similarity
is lost (“older sister cells”), indicating a non-genetic mechanism of signaling heterogeneity.
(E) Variations in signaling protein expression cause deterministic heterogeneity of signaling. A
high total expression level of a positive regulator (Xtot = X + X*) causes a strong response in a
signaling pathway with deterministic behavior. In a signaling pathway with stochastic dynamics,
the signaling response is less or not at all related to the protein content. In models of cellular
heterogeneity, protein expression is often assumed to be stable at the time scale of signaling.  
Fβ-SMAD signaling pathwayigure 2: Deterministic modeling of cellular heterogeneity. 
(A) A kinetic model of securin and cyclin B degradation by the anaphase-promoting complex
(APC)  during  mitosis  (left)  is  described  by  a  deterministic  ODE model  (see  also  [75])  and
numerically  integrated  to  simulate  the  protein  dynamics  in  one  average  cell  (middle).
Heterogeneity is introduced into the system by performing repeated simulations while sampling
protein concentrations (and in  some cases kinetic parameters)  from log-normal distributions
(right). 
(B)  Model-based  analysis  of  cellular  heterogeneity.  Fβ/SMAD signaling pathway.  or  model  analysis,  simulations  are
performed  for  varying  parameters  and/SMAD signaling pathway.  or  degree  of  protein  concentration  fluctuations,  or
different  biological  mechanisms are  considered  in  the  model.  Thereby,  the  model  provides
insights  into  molecular  sources of  heterogeneity,  mechanisms of  biological  robustness,  and
allows for the design of new experiments. 
(C) Quantitative fitting of ensemble models to heterogeneous single-cell data. In the literature,
models of cellular heterogeneity were calibrated by fitting cross-sectional snapshot data at a
particular time point, or by directly fitting the kinetic model to single-cell  trajectories. In both
cases, cell-specific parameters are estimated to yield an optimal match between model and
experiment.   
Fβ-SMAD signaling pathwayigure 3: Quantitative analysis and modeling of TGFβ-SMAD signaling pathwayβ/SMAD signalingSMAD signaling heterogeneity
(A) Schematic representation of TGFβ/SMAD signaling pathway.  β signaling including endosomal receptor shuttling, nuclear
SMAD shuttling and negative feedback: The binding of the ligand to a RII receptor leads to the
recruitment of an RI receptor building an activated receptor complex. This complex can, when
internalized, mediate the phosphorylation of SMAD2 proteins. The receptor complex either gets
degraded or free receptors are recycled back to the cells surface. In the cytosol, phosphorylated
SMAD2 proteins form trimers with SMAD4 which translocate to the nucleus, thereby incrreasing
the experimentally measurable nuclear-to-cytoplasmic (Nuc/SMAD signaling pathway.  Cyt) SMAD2 ratio. In the nucleus,
the SMAD heterotrimer acts as a transcription factor to induce downstream target  genes of
TGFβ/SMAD signaling pathway.  β  including  SMAD7  which  acts  as  a  negative  feedback  inhibiting  the  activity  of  RII
receptors.
(B)  Temporal  dynamics  of  SMAD  nuclear  translocation  at  the  single-cell  level.  Population
average (black) and standard deviation (gray shades) of the single-cell Nuc/SMAD signaling pathway.  Cyt SMAD2 ratio
after stimulation with 100 pM of TGFβ/SMAD signaling pathway.  β. Examplary trajectories of transient, sustained and non-
responding  cells  are  shown  in  different  colors  (see  legend).  Another  cell  (purple)  shows  a
bursting event (red). Data from [130].
(C)  Gradual  behavior  of  SMAD  signaling  at  the  single-cell  level.  Snapshot  histograms  of
Nuc/SMAD signaling pathway.  Cyt SMAD2 ratio 70 min (time of peak) after stimulation with varying doses of TGFβ/SMAD signaling pathway.  -b (see
legend). All  distributions are unimodal and shift towards higher mean values with increasing
stimulation. Data from [130].
(D) Three-tiered modeling approach for modeling TGFβ/SMAD signaling pathway.  β/SMAD signaling pathway.  SMAD signaling heterogeneity: In step
(1), a population-average model is fitted to experimental data. In step (2), the model is refined to
a desription of subpopulations which are identified from the measured single-cell  trajectories
using a clustering approach. Fβ/SMAD signaling pathway.  or each subpopulation, the model is fitted to the median time
courses of  a cluster,  assuming subpopulation-specific signaling  protein expression.  Step (3)
yields simulations of individual cells, since signaling protein levels are sampled from log-normal
distributions in each subpopulation model. In step (4) single-cell trajectories from step (3) are
combined according to yield a description of the complete cell population. Fβ/SMAD signaling pathway.  igure modified from
[130]
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